Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

EMCC 2011

23 - 27 Sep 2011
Shanghai, China
What drives improvements in cancer care?
Prof Kurt Miller, Prof Gordon McVie, Dr Karim Fizazi, Peter Hazenberg, Jane Grif...
What drives improvements in cancer care? ( Prof Kurt Miller, Prof Gordon McVie, Dr Karim Fizazi, Peter Hazenberg, Jane Griffiths )
13 Jan 2012
Evolving treatment options in castration-resistant prostate cancer
Prof Kurt Miller, Dr Eleni Efstathiou, Dr Karim Fizazi and Dr Göran Ahlgren
Evolving treatment options in castration-resistant prostate cancer ( Prof Kurt Miller, Dr Eleni Efstathiou, Dr Karim Fizazi and Dr Göran Ahlgren )
6 Dec 2011
The role of genomic testing in personalised medicine for breast cancer
Professor David Miles, Mount Vernon Hospital, London, UK
The role of genomic testing in personalised medicine for breast cancer ( Professor David Miles, Mount Vernon Hospital, London, UK )
6 Dec 2011
Emerging strategies for the treatment of ovarian cancer
Prof Eric Pujade-Lauraine – Hopital Hotel-Dieu, Paris, France; Prof Jonathan Led...
Emerging strategies for the treatment of ovarian cancer ( Prof Eric Pujade-Lauraine – Hopital Hotel-Dieu, Paris, France; Prof Jonathan Lederman – UCL Cancer Institute, London, UK )
2 Nov 2011
The evolving role of immunotherapy in oncology
Prof Gordon McVie; Prof Alexander Eggermont; Dr Kim Margolin; Prof Micheal Maio;...
The evolving role of immunotherapy in oncology ( Prof Gordon McVie; Prof Alexander Eggermont; Dr Kim Margolin; Prof Micheal Maio; Prof Thomas Lynch )
1 Nov 2011
Impact of imaging on radiotherapy
Mirjam Mast – Radiotherapy Centre West, The Hague, Netherlands
Impact of imaging on radiotherapy ( Mirjam Mast – Radiotherapy Centre West, The Hague, Netherlands )
28 Oct 2011
Challenges of imaging, radiation oncology, and a multidisciplinary organisation
Dr Nuria Jornet - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Challenges of imaging, radiation oncology, and a multidisciplinary organisation ( Dr Nuria Jornet - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
28 Oct 2011
Advancements in radiation oncology and medical physics
Dr Nuria jornet Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Advancements in radiation oncology and medical physics ( Dr Nuria jornet Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
28 Oct 2011
New epigenetic targets and the role of DNA methylation fingerprints in cancer tr...
Prof Manuel Esteller - University of Barcelona, Catalonia, Spain
New epigenetic targets and the role of DNA methylation fingerprints in cancer treatment ( Prof Manuel Esteller - University of Barcelona, Catalonia, Spain )
26 Oct 2011
Smaller, faster clinical trials
Dr Marie-Cecile Le Deley - Institut Gustave-Roussy, Villejuif, France
Smaller, faster clinical trials ( Dr Marie-Cecile Le Deley - Institut Gustave-Roussy, Villejuif, France )
25 Oct 2011
Sarcoma UK: providing patient support and funding sarcoma research
Roger Wilson - Sarcoma UK, London, UK
Sarcoma UK: providing patient support and funding sarcoma research ( Roger Wilson - Sarcoma UK, London, UK )
25 Oct 2011
2011 St Gallen Consensus breast cancer recommendations
Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldh...
2011 St Gallen Consensus breast cancer recommendations ( Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldhirsch – European Institute of Oncology, Milan )
25 Oct 2011
Multidisciplinary cancer care and importance of patient involvement
Prof José Mariano Gago - Instituto Superior Tecnico, Lisbon, Portugal
Multidisciplinary cancer care and importance of patient involvement ( Prof José Mariano Gago - Instituto Superior Tecnico, Lisbon, Portugal )
25 Oct 2011
Key benefits of the European Multidisciplinary Cancer Congress
Dr Karin Tamas - Szent Laszlo Teaching Hospital, Budapest, Hungary
Key benefits of the European Multidisciplinary Cancer Congress ( Dr Karin Tamas - Szent Laszlo Teaching Hospital, Budapest, Hungary )
25 Oct 2011
Opportunities for young oncologists attending EMCC 2011
Dr Katherina Farr - Aarhus University Hospital, Denmark
Opportunities for young oncologists attending EMCC 2011 ( Dr Katherina Farr - Aarhus University Hospital, Denmark )
25 Oct 2011
A new light activated technique for delivery of anti-cancer drugs
Dr Pål Selbo - Oslo University Hospital and PCI Biotech, Norway
A new light activated technique for delivery of anti-cancer drugs ( Dr Pål Selbo - Oslo University Hospital and PCI Biotech, Norway )
24 Oct 2011
Radium-223 in castration resistant prostate cancer
Dr Joaquim Bellumunt - Hospital del Mar, Barcelona, Spain
Radium-223 in castration resistant prostate cancer ( Dr Joaquim Bellumunt - Hospital del Mar, Barcelona, Spain )
21 Oct 2011
Review of prostate cancer at EMCC 2011
Dr Karim Fizazi - Institut Gustave Roussy, France
Review of prostate cancer at EMCC 2011 ( Dr Karim Fizazi - Institut Gustave Roussy, France )
21 Oct 2011
Treatment options for castration resistant prostate cancer
Dr Kurt Miller – University of Berlin, Germany
Treatment options for castration resistant prostate cancer ( Dr Kurt Miller – University of Berlin, Germany )
21 Oct 2011
Prostate cancer drug development update
Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Prostate cancer drug development update ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
21 Oct 2011
Radium 223 in the ALSYMPCA trial
Dr Chris Parker – Royal Marsden Cancer Centre, London, UK
Radium 223 in the ALSYMPCA trial ( Dr Chris Parker – Royal Marsden Cancer Centre, London, UK )
21 Oct 2011
Mechanisms of DNA damage processing in stem cells
Prof Pier Giuseppe - European Institute of Oncology, Milan, Italy
Mechanisms of DNA damage processing in stem cells ( Prof Pier Giuseppe - European Institute of Oncology, Milan, Italy )
21 Oct 2011
Latest in renal carcinoma
Dr James Larkin - The Royal Marsden, London, UK
Latest in renal carcinoma ( Dr James Larkin - The Royal Marsden, London, UK )
21 Oct 2011
Effect of economic, technological and social changes on global cancer burden
Dr James Bellini – Freelance Futurologist
Effect of economic, technological and social changes on global cancer burden ( Dr James Bellini – Freelance Futurologist )
21 Oct 2011
Advances in the prevention of cervical cancer
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Advances in the prevention of cervical cancer ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
21 Oct 2011
President of ECCO on EMCC 2011
Prof Michael Baumann, President of the European CanCer Organisation, Brussels, B...
President of ECCO on EMCC 2011 ( Prof Michael Baumann, President of the European CanCer Organisation, Brussels, Belgium )
21 Oct 2011
Evolving landscape in castration-resistant prostate cancer
Dr Per-Anders Abrahamsson - Lund University, Sweden; Dr Chris Parker - Royal Mar...
Evolving landscape in castration-resistant prostate cancer ( Dr Per-Anders Abrahamsson - Lund University, Sweden; Dr Chris Parker - Royal Marsden Cancer Center, London, UK )
21 Oct 2011
Immunotherapy treatment for melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Immunotherapy treatment for melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2011
Angiogenesis therapy for colon cancer
Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA
Angiogenesis therapy for colon cancer ( Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA )
21 Oct 2011
Elimination of ageism from oncology
Dr Joanna Kazmierska - Great Poland Cancer Centre, Poznan, Poland
Elimination of ageism from oncology ( Dr Joanna Kazmierska - Great Poland Cancer Centre, Poznan, Poland )
21 Oct 2011
Vemurafenib improves survival in melanoma with BRAF V600E mutation
Dr Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Vemurafenib improves survival in melanoma with BRAF V600E mutation ( Dr Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
21 Oct 2011
Role of advance practice nurses in survivor care
Mary Macabe - Memorial Sloan-Kettering Cancer Center, New York City, US
Role of advance practice nurses in survivor care ( Mary Macabe - Memorial Sloan-Kettering Cancer Center, New York City, US )
21 Oct 2011
Use of circulating tumour cells as a prognostic or predictive marker
Prof Caroline Dive - Paterson Institute for Cancer Research, Manchester, UK
Use of circulating tumour cells as a prognostic or predictive marker ( Prof Caroline Dive - Paterson Institute for Cancer Research, Manchester, UK )
20 Oct 2011
Advances in the treatment of rectal cancer
Dr Colette van den Broek - Leiden University Medical Centre, Netherlands
Advances in the treatment of rectal cancer ( Dr Colette van den Broek - Leiden University Medical Centre, Netherlands )
20 Oct 2011
EurocanPlatform - building a platform for translational research
Prof Ulrik Ringborg - Karolinska Institutet, Stockholm, Sweden
EurocanPlatform - building a platform for translational research ( Prof Ulrik Ringborg - Karolinska Institutet, Stockholm, Sweden )
20 Oct 2011
Patterns of cancer incidence and mortality in Europe
Prof David Forman - International Agency for Research on Cancer, Lyon, France
Patterns of cancer incidence and mortality in Europe  ( Prof David Forman - International Agency for Research on Cancer, Lyon, France )
20 Oct 2011
Key gastrointestinal cancer research from EMCC 2011
Prof Eric van Cutsem - University Hospital Gasthuisberg, Leuven, Belgium
Key gastrointestinal cancer research from EMCC 2011 ( Prof Eric van Cutsem - University Hospital Gasthuisberg, Leuven, Belgium )
20 Oct 2011
Synchronous chemoradiation significantly reduces the risk of the breast cancer r...
Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK
Synchronous chemoradiation significantly reduces the risk of the breast cancer recurrence ( Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK )
20 Oct 2011
Effects of radiotherapy on the immune system
Dr Silvie Formantini – NYU Langone Medical Center, New York City, US
Effects of radiotherapy on the immune system ( Dr Silvie Formantini – NYU Langone Medical Center, New York City, US )
20 Oct 2011
Recent advances in advanced breast cancer
Prof Stephen Johnston; Prof Johanna Mattson; Prof Ahmad Awada; Prof Rob Coleman
Recent advances in advanced breast cancer ( Prof Stephen Johnston; Prof Johanna Mattson; Prof Ahmad Awada; Prof Rob Coleman )
18 Oct 2011
Advances in the treatment of lung cancer and melanoma
Dr Raffaele Califano - The Christie NHS Foundation Trust, Manchester, UK
Advances in the treatment of lung cancer and melanoma ( Dr Raffaele Califano - The Christie NHS Foundation Trust, Manchester, UK )
17 Oct 2011
Looking forward to the 2012 ESTRO meeting
Dr Brad Wouters - Ontario Institute for Cancer Research, Toronto, Canada
Looking forward to the 2012 ESTRO meeting ( Dr Brad Wouters - Ontario Institute for Cancer Research, Toronto, Canada )
17 Oct 2011
Influence of regenerative stem cells and cell microenvironment upon treatment su...
Dr Brad Wouters - Ontario Institute for Cancer Research, Toronto, Canada
Influence of regenerative stem cells and cell microenvironment upon treatment success ( Dr Brad Wouters - Ontario Institute for Cancer Research, Toronto, Canada )
17 Oct 2011
The FLIMS Alumni Club
Dr Duveken Fontein - PhD breast cancer researcher and FLIMS alumnus
The FLIMS Alumni Club ( Dr Duveken Fontein - PhD breast cancer researcher and FLIMS alumnus )
17 Oct 2011
Benefits of the EMCC congress for young oncologists
Dr Duveken Fontein - Leiden University Medical Center, Holland
Benefits of the EMCC congress for young oncologists ( Dr Duveken Fontein - Leiden University Medical Center, Holland )
17 Oct 2011
Message from the President-Elect of ESTRO
Prof Donal Hollywood - Trinity College, Dublin, Ireland
Message from the President-Elect of ESTRO ( Prof Donal Hollywood - Trinity College, Dublin, Ireland )
17 Oct 2011
Message from the President of ESTRO
Prof Vincenzo Valentini - Università Cattolica del Sacro Cuore, Rome, Italy
Message from the President of ESTRO ( Prof Vincenzo Valentini - Università Cattolica del Sacro Cuore, Rome, Italy )
17 Oct 2011
Multi-disciplinary approaches and e-learning within ESTRO
Prof Vincenzo Valentini - Università Cattolica del Sacro Cuore, Rome, Italy
Multi-disciplinary approaches and e-learning within ESTRO ( Prof Vincenzo Valentini - Università Cattolica del Sacro Cuore, Rome, Italy )
17 Oct 2011
Cancer risk communication
Carol Maddock - Cancer Communications Researcher, Tenovus
Cancer risk communication ( Carol Maddock - Cancer Communications Researcher, Tenovus )
17 Oct 2011
Mutations of the SF3B1 gene
Dr Elli Papaemmanuil - Institute of Cancer Research, Sutton, UK
Mutations of the SF3B1 gene ( Dr Elli Papaemmanuil - Institute of Cancer Research, Sutton, UK )
11 Oct 2011
60 years in oncology
Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy
60 years in oncology ( Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy )
6 Oct 2011
Aflibercept vs placebo and FOLFIRI for MCRC
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Aflibercept vs placebo and FOLFIRI for MCRC ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
4 Oct 2011
Roundup of the EMCC 2011 conference
Prof Gordon McVie - European Institute of Oncology and ecancer
Roundup of the EMCC 2011 conference ( Prof Gordon McVie - European Institute of Oncology and ecancer )
3 Oct 2011
Affordable cancer care in high-income countries
Prof Richard Sullivan - King's College London, UK; Dr Peter Naredi - Umea Univer...
Affordable cancer care in high-income countries ( Prof Richard Sullivan - King's College London, UK; Dr Peter Naredi - Umea University, Sweden )
28 Sep 2011
Effects of chemotherpay during pregnancy
Prof Frederic Amant - University Hospitals Leuven, Belgium
Effects of chemotherpay during pregnancy ( Prof Frederic Amant - University Hospitals Leuven, Belgium )
27 Sep 2011
Links between high blood pressure and cancer
Prof Mieke Van Hemelrijck - King's College, London, UK
Links between high blood pressure and cancer ( Prof Mieke Van Hemelrijck - King's College, London, UK )
27 Sep 2011
The BOLERO-2 study confirms everolimus and exemestane in ER/PR+ advanced breast ...
Prof José Baselga – Massachusetts General Hospital Cancer Center, USA
The BOLERO-2 study confirms everolimus and exemestane in ER/PR+ advanced breast cancer improves PFS ( Prof José Baselga – Massachusetts General Hospital Cancer Center, USA )
26 Sep 2011
Trastuzumab emtansine, Phase II trial for HER2
Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
Trastuzumab emtansine, Phase II trial for HER2 ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
25 Sep 2011
Radiotherapy between or during chemo cycles for breast cancer
Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK
Radiotherapy between or during chemo cycles for breast cancer ( Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK )
25 Sep 2011
Denosumab delays metastases for prostate cancer
Prof Stephane Oudard - Georges Pompidou European Hospital, France
Denosumab delays metastases for prostate cancer ( Prof Stephane Oudard - Georges Pompidou European Hospital, France )
25 Sep 2011
Zoledronic acid reduces recurrence of breast cancer
Prof Robert Coleman - Weston Park Hospital, Sheffield, UK
Zoledronic acid reduces recurrence of breast cancer ( Prof Robert Coleman - Weston Park Hospital, Sheffield, UK )
25 Sep 2011
Experimenting with smaller, faster clinical trials
Dr Marie-Cecile Le Deley - Institut Gustave-Roussy, Villejuif, France
Experimenting with smaller, faster clinical trials ( Dr Marie-Cecile Le Deley - Institut Gustave-Roussy, Villejuif, France )
25 Sep 2011
Frequency of biopsies for breast cancer tumours
Dr Linda Lindstrom - Karolinska Institutet, Stockholm, Sweden
Frequency of biopsies for breast cancer tumours ( Dr Linda Lindstrom - Karolinska Institutet, Stockholm, Sweden )
25 Sep 2011
Chemotherapy infusions directly to organs
Prof James Pingpank - University of Pittsburgh School of Medicine, USA
Chemotherapy infusions directly to organs ( Prof James Pingpank - University of Pittsburgh School of Medicine, USA )
24 Sep 2011
Phase III trial of an alpha-pharmaceutical
Dr Chris Parker - The Royal Marsden Cancer Centre, London, UK
Phase III trial of an alpha-pharmaceutical ( Dr Chris Parker - The Royal Marsden Cancer Centre, London, UK )
24 Sep 2011
Cost effective ways to predict prostate cancer 2/2
Dr David Orsted - Copenhagen University Hospital, Denmark
Cost effective ways to predict prostate cancer 2/2 ( Dr David Orsted - Copenhagen University Hospital, Denmark )
24 Sep 2011
Cost effective ways to predict prostate cancer 1/2
Dr Stig Bojesen - Copenhagen University Hospital, Denmark
Cost effective ways to predict prostate cancer 1/2 ( Dr Stig Bojesen - Copenhagen University Hospital, Denmark )
24 Sep 2011
Personalising medicine and the panel’s predictions for oncotechnologies (2/4)
Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientif...
Personalising medicine and the panel’s predictions for oncotechnologies (2/4) ( Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientific Co-Chair (ESMO); Peter Naredi - Surgery Vice Chair )
11 Apr 2011
Multidisciplinary mass gathering and celebration of European basic, translationa...
Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; ...
Multidisciplinary mass gathering and celebration of European basic, translational and clinical studies (5/5) ( Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO) )
11 Apr 2011
Oncopolicy: tackling the inequalities in cancer research and care across Europe ...
Michael Baumann - ECCO President & Congress Chair
Oncopolicy: tackling the inequalities in cancer research and care across Europe (4/5) ( Michael Baumann - ECCO President & Congress Chair )
11 Apr 2011
Serendipity of cancer science & programme highlights (3/5)
Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; ...
Serendipity of cancer science & programme highlights (3/5) ( Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO) )
11 Apr 2011
Personalised medicine: how the 2011 Multidisciplinary Cancer Congress will mark ...
Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; ...
Personalised medicine: how the 2011 Multidisciplinary Cancer Congress will mark important milestones in getting the right treatment to the right patient at the right time (2/5) ( Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO) )
11 Apr 2011
Bench, bedside, ‘bytes’ and back: a virtuous cycle of knowledge (1/5)
Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; ...
Bench, bedside, ‘bytes’ and back: a virtuous cycle of knowledge (1/5) ( Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO) )
11 Apr 2011
Concluding remarks (4/4)
Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientif...
Concluding remarks (4/4) ( Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientific Co-Chair (ESMO); Peter Naredi - Surgery Vice Chair )
11 Apr 2011
Role, relevance and participation of all stakeholders in oncology (3/4)
Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientif...
Role, relevance and participation of all stakeholders in oncology (3/4) ( Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientific Co-Chair (ESMO); Peter Naredi - Surgery Vice Chair )
11 Apr 2011
Advancing multidisciplinary cancer management (1/4)
Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientif...
Advancing multidisciplinary cancer management (1/4) ( Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientific Co-Chair (ESMO); Peter Naredi - Surgery Vice Chair )
11 Apr 2011
Battling rare cancers in Europe - access and ethics
Kathy Oliver (International Brain Tumour Alliance), Tom Hudson (Europa Uomo), An...
Battling rare cancers in Europe - access and ethics ( Kathy Oliver (International Brain Tumour Alliance), Tom Hudson (Europa Uomo), Anita Waldmann (Myeloma Euronet), Gerlind Bode (ICCCPO) )
17 Mar 2011
Access to new tailored cancer therapies and reliable patient information - the c...
Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen V...
Access to new tailored cancer therapies and reliable patient information - the challenges ( Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna) )
17 Mar 2011
Ethical considerations surrounding cancer in the elderly and the pros and cons o...
Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen V...
Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources ( Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna) )
17 Mar 2011